Can bioanalytical tools solve your neurodegenerative disease research challenges? 4 questions to ask yourself January 21, 2021 Despite extensive efforts, neurodegenerative diseases (ND) continue to feel like a pharmaceutical frontier. We have… Monolith Products
3 case studies on how to characterize challenging drug discovery targets — membrane proteins, peptide libraries, and PROTACs December 18, 2020 A caveat to a successful pharmaceutical industry in which many effective drugs have already been… Dianthus
How Amgen looks at stability characterization to boost the success of biologics candidates December 3, 2020 Biologic drugs have been incredibly successful in terms of both medical achievement and profitability. Many… Prometheus
What to consider before accepting an offer to start your lab October 29, 2020 Starting your own lab is a very exciting and rewarding opportunity. And, even if you… Customer support
How to convince researchers to join your new lab (over more established ones) October 15, 2020 Starting a new lab as a principal investigator is an exhilarating endeavor. However, you’re met… Customer support
A guide to drafting an all-star team for your lab October 8, 2020 As a new principal investigator, you now have a leadership role, guiding your lab members… Customer support
Characterize the true nature of intrinsically disordered proteins without immobilizing them October 1, 2020 If you study neurodegenerative diseases (ND), you already know they are one of the most… Monolith
NanoTemper Technologies launches DLS capability with Prometheus Panta, bringing high-resolution, domain-specific stability characterization to biologics September 24, 2020 Prometheus, the new gold standard, now provides clarity to the most challenging stability characterizations Products Prometheus
Seven tips to give your grant proposal that extra edge September 17, 2020 Grant writing is an important bread-and-butter skill that all principal investigators must develop, as this… Customer support